Retraction notices

Clinical practice of epidermal growth factor receptor-tyrosine kinase inhibitor targeted drugs combined with gadolinium oxide nanoparticles in the treatment of non-small cell lung cancer

Type

Retraction

Notice date

2/20/2024 0:00

Journal

Bioengineered

Publisher

Taylor and Francis

Notice DOI

10.1080/21655979.2024.2299626

Original paper DOI

10.1080/21655979.2021.2009969

Reasons

• Concerns/Issues about Data
• Concerns/Issues about Results and/or Conclusions
• Original Data and/or Images not Provided and/or not Available

Matching venue names

Name match only, not an authoritative journal identifier.

• Bioengineered